Drug Repurposing as a Source of Innovative Therapies in Cervical Cancer
Presented at the European Society of Gynaecological Oncology Annual Conference 2021 in Prague
How to capture real-world data to prove efficacy of repurposed drugs?
METRO-PD1: A Phase I Feasibility Study Evaluating Anti-PD1 (NIVOLUMAB) In Combination With Metronomic Chemotherapy In Children And Teenagers With Refractory/Relapsing Solid Tumors Or Lymphoma
Presented at SIOP 2021 Congress
Clinical research in surgical oncology matters
The Anticancer Fund is participating in the World Cancer Series organised by The Economist
